DRUG

baricitinib

2 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for baricitinib

ALS 1

Mediator Outcome Score Tier Lit. status Trial
MCP-1 ALS 0.220 Mid partial evidence completed

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
JAK2 poor prognosis 0.353 High reproduces known none

Clinical trials

189 registered trials for baricitinib

Source: ClinicalTrials.gov